Gastroenterology
News
Integrin receptor antagonist approved for IBD, with postmarketing safety plans
Conference Coverage
Fecal transplant falls short in UC, but may not be the end
Key clinical finding: Fecal microbiota transplant is not ready for ulcerative colitis yet.Major finding: Remission was achieved by seven FMT...
News
Pancreatic cancer predicted to become second-leading cause of U.S. cancer deaths by 2030
Major finding: In the United States, pancreatic and liver cancers are projected to overtake breast, prostate, and colorectal cancers to become the...
Conference Coverage
Insulin perturbations seen in nondiabetic patients with NAFLD
Major finding: The mean fasting insulin level was 14.3 microIU/mL, and mean insulin levels on an OGTT exceeded the upper limit of normal from 60...
News
Magnetic foreign body injury rate on the rise
Key clinical point: Parents and providers should be aware of dangers posed by today’s smaller, stronger magnets, especially if ingested in...
News
Mindfulness improved irritable bowel for a year
Major finding: IBS Severity Scale scores improved in the mindfulness group by 151 points at 6 months and by 115 points at 12 months, compared with...
Conference Coverage
Eccentric exercise tamed elevated liver enzymes
Major finding: An exercise regimen of regular downhill walking for 8 weeks lowered serum alanine aminotransferase levels in overweight and obese...
News
Posaconazole disappoints against chronic Chagas’ disease
Major finding: The primary end point of the study, consistently negative results on serial T.
News
Undiagnosed joint hypermobility syndrome prevalent in GI clinics
Major finding: Joint hypermobility syndrome is significantly associated with gastrointestinal symptoms such as abdominal pain, bloating, and...
News
UPDATED: FDA-released safety data on dabigatran vs. warfarin reassuring
Major finding: The risks of ischemic stroke, intracranial hemorrhage, and death associated with dabigatran treatment were lower than with warfarin...
Conference Coverage
PEARL-II: Oral ‘3D’ regimen effective in hepatitis C with prior treatment failure
Major finding: Noncirrhotic patients with hepatitis C genotype 1b disease who had failed previous pegylated interferon–based therapy had a 100%...